Craig C. Hofmeister, MD, MPH

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (448 ratings)

Role

Hematology Oncology
Specialty

Myeloma and Plasma Cell Disorders
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2006

Request Appointment

Background

Craig C. Hofmeister, MD, MPH, is board certified in hematology and his practice focuses on plasma cell cancers including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma and monoclonal gammopathies of clinical significance. He started practicing with Emory Healthcare in 2018. Dr. Hofmeister is a professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.

Dr. Hofmeister earned his Medical Degree and his Master of Public Health in Clinical Investigation from The Ohio State University in Columbus, Ohio. He completed his internship and hematology fellowship at Loyola University.

Titles & Roles

Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, , 2006
Loyola Univ. Medical Center
Fellowship, Hematology/Oncology, 2005
Loyola Univ. Medical Center
Residency, Internal Medicine, 2002
Loyola Univ. Medical Center
Medical Education, ,
Ohio State University College of Medicine

Board Certifications

Hematology
American Board of Internal Medicine, 2005
Internal Medicine
American Board of Internal Medicine, 2002

Research

Dr. Hofmeister's research focus is on early drug development and the use of large datasets to ask and answer pertinent questions as a translational informaticist.

View Current Clinical Trials


A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma Phase I Conditions Multiple Myeloma Location Winship Cancer Institute
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis Phase I Conditions AL Amyloidosis Location Winship Cancer Institute
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma Phase I Conditions Multiple Myeloma Location Winship Cancer Institute
A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) Phase I/II Conditions Multiple Myeloma Location Emory University Hospital Midtown, Winship Cancer Institute

Title/Journal	Authors	Publication Date
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience. Blood cancer journal	SA Scott, EM Marin, KT Maples, NS Joseph, CC Hofmeister, VA Gupta, MV Dhodapkar, JL Kaufman, S Lonial, AK Nooka	20/12/2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. Oncotarget	A Canella, HC Nieves, DW Sborov, L Cascione, HS Radomska, E Smith, A Stiff, J Consiglio, E Caserta, L Rizzotto, N Zanesi, V Stefano, B Kaur, X Mo, JC Byrd, YA Efebera, CC Hofmeister, F Pichiorri	25/09/2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity. Research square	A Moreno, K Manning, MI Azeem, AK Nooka, M Ellis, RJ Manalo, JM Switchenko, B Wali, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, KM Dhodapkar, MV Dhodapkar, MS Suthar	21/09/2023
Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction. JCO oncology practice	LF Sun, KT Maples, KH Hall, Y Liu, Y Cao, NS Joseph, CC Hofmeister, JL Kaufman, M Dhodapkar, AK Nooka, S Lonial, RD Harvey	01/09/2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity. bioRxiv : the preprint server for biology	A Moreno, K Manning, MI Azeem, AK Nooka, M Ellis, RJ Manalo, JM Switchenko, B Wali, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, KM Dhodapkar, MV Dhodapkar, MS Suthar	22/08/2023
PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant. Haematologica	M Thomas, J Li, K King, AK Persaud, E Duah, Z Vangundy, CC Hofmeister, JK Lamba, AC Tan, BL Fridley, MJ Poi, ND Seligson	01/08/2023
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy. The Journal of clinical investigation	MH Robinson, NY Villa, DL Jaye, AK Nooka, A Duffy, SS McCachren, J Manalo, JM Switchenko, S Barnes, S Potdar, MI Azeem, AA Horvat, VC Parihar, J Gong, Y Liang, GH Smith, VA Gupta, LH Boise, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, KM Dhodapkar, MV Dhodapkar	01/08/2023
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections. Blood cancer discovery	MI Azeem, AK Nooka, U Shanmugasundaram, N Cheedarla, S Potdar, RJ Manalo, A Moreno, JM Switchenko, S Cheedarla, DB Doxie, R Radzievski, ML Ellis, KE Manning, B Wali, RM Valanparambil, KT Maples, E Baymon, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, JD Roback, A Sette, R Ahmed, MS Suthar, AS Neish, MV Dhodapkar, KM Dhodapkar	01/03/2023
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience. Blood cancer journal	KT Maples, KH Hall, NS Joseph, CC Hofmeister, V Gupta, MV Dhodapkar, JL Kaufman, AK Nooka, S Lonial	20/02/2023
Evaluating the Impacts of CYP3A41B and CYP3A53 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant. Cancer genomics & proteomics	J Li, YK Cho, DW Sborov, MA Phelps, CC Hofmeister, MJ Poi	01/01/2023
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma. Leukemia	M Slade, TG Martin, N Nathwani, MA Fiala, MP Rettig, F Gao, A Deol, FK Buadi, JL Kaufman, CC Hofmeister, TK Gregory, J Berdeja, A Chari, A Rosko, R Vij	01/12/2022
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	AK Nooka, U Shanmugasundaram, N Cheedarla, H Verkerke, VV Edara, R Valanparambil, JL Kaufman, CC Hofmeister, NS Joseph, S Lonial, M Azeem, J Manalo, JM Switchenko, A Chang, SL Linderman, JD Roback, KM Dhodapkar, R Ahmed, MS Suthar, AS Neish, MV Dhodapkar	10/09/2022
Venetoclax ex vivo functional profiling predicts improved progression-free survival. Blood cancer journal	VA Gupta, SM Matulis, BG Barwick, RD Bog, CW Shebelut, M Shanmugam, P Neri, NJ Bahlis, MV Dhodapkar, LT Heffner, CC Hofmeister, NS Joseph, S Lonial, JL Kaufman, DL Jaye, AK Nooka, LH Boise	04/08/2022
Impact of concurrent gabapentin or pregabalin with high-dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Pharmacotherapy	A Sivakumar, EB Bryson, KH Hall, KT Maples, S Goyal, NS Joseph, CC Hofmeister, JL Kaufman, S Lonial, AK Nooka, RD Harvey	01/03/2022
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. American journal of hematology	RF Cornell, R Baz, JR Richter, A Rossi, DT Vogl, C Chen, C Shustik, MJ Alvarez, Y Shen, TJ Unger, O Ben-Shahar, H Wang, E Baloglu, W Senapedis, X Ma, Y Landesman, X Bai, J Bader, H Xu, T Marshall, H Chang, CJ Walker, J Shah, S Shacham, MG Kauffman, CC Hofmeister	01/02/2022
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life. Transplantation and cellular therapy	NS Joseph, VA Gupta, S Wyman, M Graiser, JL Kaufman, D Almaula, J Andrews, C Hofmeister, M Dhodapkar, LT Heffner, S Lonial, AK Nooka	01/02/2022
A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy. Anticancer research	J Li, AK Persaud, JA Johnson, DW Sborov, MA Phelps, CC Hofmeister, MJ Poi	01/01/2022
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia. Blood cancer discovery	A Kaushal, AK Nooka, AR Carr, KE Pendleton, BG Barwick, J Manalo, SS McCachren, VA Gupta, NS Joseph, CC Hofmeister, JL Kaufman, LT Heffner, SM Ansell, LH Boise, S Lonial, KM Dhodapkar, MV Dhodapkar	01/11/2021
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing. European journal of drug metabolism and pharmacokinetics	S Liva, M Chen, A Mortazavi, A Walker, J Wang, K Dittmar, C Hofmeister, CC Coss, MA Phelps	01/11/2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas. Laryngoscope investigative otolaryngology	DB Welling, KA Collier, SS Burns, JL Oblinger, E Shu, BA Miles-Markley, CC Hofmeister, MS Makary, HW Slone, JO Blakeley, SA Mansouri, BA Neff, RK Jackler, A Mortazavi, LS Chang	01/10/2021
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood	VA Gupta, BG Barwick, SM Matulis, R Shirasaki, DL Jaye, JJ Keats, B Oberlton, NS Joseph, CC Hofmeister, LT Heffner, MV Dhodapkar, AK Nooka, S Lonial, CS Mitsiades, JL Kaufman, LH Boise	01/07/2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research	BG Barwick, VA Gupta, SM Matulis, JC Patton, DR Powell, Y Gu, DL Jaye, KN Conneely, YC Lin, CC Hofmeister, AK Nooka, JJ Keats, S Lonial, PM Vertino, LH Boise	01/06/2021
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer chemotherapy and pharmacology	KA Collier, H Valencia, H Newton, EM Hade, DW Sborov, R Cavaliere, M Poi, MA Phelps, SG Liva, CC Coss, J Wang, S Khountham, P Monk, CL Shapiro, R Piekarz, CC Hofmeister, DB Welling, A Mortazavi	01/05/2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo. Molecular therapy oncolytics	J Ghose, A Dona, M Murtadha, EG Gunes, E Caserta, JY Yoo, L Russell, AC Jaime-Ramirez, BG Barwick, VA Gupta, JF Sanchez, DW Sborov, ST Rosen, A Krishnan, LH Boise, B Kaur, CC Hofmeister, F Pichiorri	26/03/2021
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience. American journal of hematology	KT Maples, AK Nooka, V Gupta, NS Joseph, LT Heffner, C Hofmeister, M Dhodapkar, SM Matulis, S Lonial, LH Boise, JL Kaufman	01/03/2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial. Frontiers in immunology	P Shindiapina, M Pietrzak, M Seweryn, E McLaughlin, X Zhang, M Makowski, EH Ahmed, S Schlotter, R Pearson, R Kitzler, A Mozhenkova, J Le-Rademacher, RF Little, G Akpek, E Ayala, SM Devine, LD Kaplan, A Noy, UR Popat, JW Hsu, LE Morris, AM Mendizabal, A Krishnan, W Wachsman, N Williams, N Sharma, CC Hofmeister, SJ Forman, WH Navarro, JC Alvarnas, RF Ambinder, G Lozanski, RA Baiocchi	01/01/2021
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting. Leukemia	D Viola, A Dona, E Caserta, E Troadec, F Besi, T McDonald, L Ghoda, EG Gunes, JF Sanchez, J Khalife, M Martella, C Karanes, M Htut, X Wang, M Rosenzweig, A Chowdhury, D Sborov, RR Miles, PJ Yazaki, T Ebner, CC Hofmeister, SJ Forman, ST Rosen, G Marcucci, J Shively, JJ Keats, A Krishnan, F Pichiorri	01/01/2021
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma. Blood cancer journal	Y Gu, BG Barwick, M Shanmugam, CC Hofmeister, J Kaufman, A Nooka, V Gupta, M Dhodapkar, LH Boise, S Lonial	14/12/2020
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant. British journal of clinical pharmacology	K Sweiss, B Vemu, CC Hofmeister, E Wenzler, GS Calip, JP Galvin, N Mahmud, D Rondelli, JJ Johnson, P Patel	01/11/2020
Association of ANRIL Polymorphism With Overall Survival in Adult Patients With Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation. Anticancer research	J Li, N Seligson, X Zhang, J Johnson, Z Vangundy, D Wang, M Phelps, C Hofmeister, W Sadee, MJ Poi	01/10/2020
Characterizing Pain Experiences: African American Patients With Multiple Myeloma Taking Around-the-Clock Opioids. Clinical journal of oncology nursing	SM Belcher, D Watkins Bruner, CC Hofmeister, J Kweon, SH Meghani, KA Yeager	01/10/2020
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia	M Gavriatopoulou, A Chari, C Chen, N Bahlis, DT Vogl, A Jakubowiak, D Dingli, RF Cornell, CC Hofmeister, D Siegel, JG Berdeja, D Reece, D White, S Lentzsch, C Gasparetto, CA Huff, S Jagannath, R Baz, AK Nooka, J Richter, R Abonour, TL Parker, AJ Yee, P Moreau, S Lonial, S Tuchman, KC Weisel, M Mohty, S Choquet, TJ Unger, K Li, Y Chai, L Li, J Shah, S Shacham, MG Kauffman, MA Dimopoulos	01/09/2020
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS). Leukemia	CO Landgren, A Chari, YC Cohen, A Spencer, P Voorhees, JA Estell, I Sandhu, MW Jenner, C Williams, M Cavo, NWCJ van de Donk, M Beksac, P Moreau, H Goldschmidt, S Kuppens, R Bandekar, PL Clemens, T Neff, C Heuck, M Qi, CC Hofmeister	01/07/2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	NS Joseph, JL Kaufman, MV Dhodapkar, CC Hofmeister, DK Almaula, LT Heffner, VA Gupta, LH Boise, S Lonial, AK Nooka	10/06/2020
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	N Sharma, DT Chen, Q Zhao, NY Williams, A Rosko, DM Benson, M Chaudhry, N Bumma, A Khan, S Devarakonda, CC Hofmeister, D Sborov, YA Efebera	01/01/2020
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant. Molecular carcinogenesis	AK Persaud, J Li, JA Johnson, N Seligson, DW Sborov, E Duah, YK Cho, D Wang, MA Phelps, CC Hofmeister, MJ Poi	01/12/2019
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood cancer journal	TM Schmidt, BG Barwick, N Joseph, LT Heffner, CC Hofmeister, L Bernal, MV Dhodapkar, VA Gupta, DL Jaye, J Wu, S Goyal, Z Chen, LH Boise, S Lonial, AK Nooka, JL Kaufman	25/11/2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages. JCI insight	J Khalife, J Ghose, M Martella, D Viola, A Rocci, E Troadec, C Terrazas, AR Satoskar, EG Gunes, A Dona, JF Sanchez, PL Bergsagel, M Chesi, A Pozhitkov, S Rosen, G Marcucci, JJ Keats, CC Hofmeister, A Krishnan, E Caserta, F Pichiorri	01/11/2019
BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas. Bone marrow transplantation	S Singer, N Sharma, R Dean, Q Zhao, D Abounader, P Elder, CC Hofmeister, DM Benson, A Rosko, S Penza, L Andritsos, S Vasu, S Jaglowski, BM William, B Bolwell, B Pohlman, M Kalaycio, D Jagadeesh, B Hill, R Sobecks, SM Devine, NS Majhail, YA Efebera	01/10/2019
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. Leukemia research	LA Andritsos, Y Huang, I Abraham, K Huff, SR Scrape, T Fan, N Alkhatib, CC Hofmeister, E Drea, A McBride	01/10/2019
Daratumumab in multiple myeloma. Cancer	AK Nooka, JL Kaufman, CC Hofmeister, NS Joseph, TL Heffner, VA Gupta, HC Sullivan, AS Neish, MV Dhodapkar, S Lonial	15/07/2019
Registering a CD38 antibody upfront for multiple myeloma. Lancet (London, England)	CC Hofmeister, A Nooka, JL Kaufman, S Lonial	06/07/2019
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Singer, R Dean, Q Zhao, N Sharma, D Abounader, P Elder, CC Hofmeister, DM Benson, A Rosko, S Penza, L Andritsos, S Vasu, S Jaglowski, BM William, B Bolwell, B Pohlman, M Kalaycio, D Jagadeesh, B Hill, R Sobecks, SM Devine, NS Majhail, YA Efebera	01/06/2019
Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease? Bone marrow transplantation	JL Vaughn, Q Zhao, N Epperla, M Puto, J Roddy, P Elder, W Blum, R Klisovic, S Jaglowski, S Penza, B William, L Andritsos, JE Brammer, C Hofmeister, Y Efebera, D Benson, S Devine, S Cataland, S Vasu	01/06/2019
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies. European journal of haematology	MA Dimopoulos, JP Laubach, MA Echeveste Gutierrez, N Grzasko, CC Hofmeister, JF San-Miguel, S Kumar, R Labotka, V Lu, D Berg, C Byrne, Z Teng, G Liu, H van de Velde, PG Richardson	01/06/2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies. British journal of clinical pharmacology	JH Hughes, MA Phelps, RN Upton, SE Reuter, Y Gao, JC Byrd, MR Grever, CC Hofmeister, G Marcucci, W Blum, KA Blum, DJR Foster	01/05/2019
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. JCI insight	JK Bailur, SS McCachren, DB Doxie, M Shrestha, K Pendleton, AK Nooka, N Neparidze, TL Parker, N Bar, JL Kaufman, CC Hofmeister, LH Boise, S Lonial, ML Kemp, KM Dhodapkar, MV Dhodapkar	23/04/2019
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis. Nature communications	BG Barwick, P Neri, NJ Bahlis, AK Nooka, MV Dhodapkar, DL Jaye, CC Hofmeister, JL Kaufman, VA Gupta, D Auclair, JJ Keats, S Lonial, PM Vertino, LH Boise	23/04/2019
Most multiple myeloma patients have low testosterone. Leukemia & lymphoma	S John, N Sharma, DW Sborov, N Williams, D Jones, DM Benson, YA Efebera, AE Rosko, J Vincent, CC Hofmeister	01/03/2019
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents. Cancer	R Mina, NS Joseph, JL Kaufman, VA Gupta, LT Heffner, CC Hofmeister, LH Boise, MV Dhodapkar, C Gleason, AK Nooka, S Lonial	01/02/2019
A Single Nucleotide Polymorphism in SLC7A5 Was Associated With Clinical Response in Multiple Myeloma Patients. Anticancer research	MJ Poi, J Li, JA Johnson, YK Cho, DW Sborov, MA Phelps, CC Hofmeister	01/01/2019
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT). Archives of hematology and blood diseases	A Pandit, L Wei, L Bustamante, P Elder, WBS Falk, M Sell, A Rosko, DM Benson, SM Devine, CC Hofmeister, YA Efebera	01/01/2019
Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients. Bone marrow transplantation	DR Richardson, Y Huang, HL McGinty, P Elder, J Newlin, C Kirkendall, L Andritsos, D Benson, W Blum, Y Efebera, S Penza, C Hofmeister, S Jaglowski, R Klisovic, S Vasu, B William, S Devine, AE Rosko	01/11/2018
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant. CPT: pharmacometrics & systems pharmacology	YK Cho, DJ Irby, J Li, DW Sborov, DR Mould, M Badawi, A Dauki, M Lamprecht, AE Rosko, S Fernandez, EM Hade, CC Hofmeister, M Poi, MA Phelps	01/11/2018
Ninety-minute daratumumab infusion is safe in multiple myeloma. Leukemia	H Barr, J Dempsey, A Waller, Y Huang, N Williams, N Sharma, DM Benson, AE Rosko, YA Efebera, CC Hofmeister	01/11/2018
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma. British journal of haematology	PG Richardson, CC Hofmeister, CA Rosenbaum, M Htut, DH Vesole, JG Berdeja, M Liedtke, A Chari, SD Smith, D Lebovic, N Raje, C Byrne, E Liao, N Gupta, AD Bacco, J Estevam, D Berg, R Baz	01/07/2018
Daratumumab induces CD38 internalization and impairs myeloma cell adhesion. Oncoimmunology	J Ghose, D Viola, C Terrazas, E Caserta, E Troadec, J Khalife, EG Gunes, J Sanchez, T McDonald, G Marcucci, B Kaur, M Rosenzweig, J Keats, S Rosen, A Krishnan, AR Satoskar, CC Hofmeister, F Pichiorri	01/01/2018

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.8	One star One star One star One star One half star	Provider discussed treatment options
4.8	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	09/05/2024	Great feedback and answered my questions.
One star One star One star One star One star	27/04/2024	Awesome doctor with extraordinary manner
One star One star One star One star One star	24/04/2024	The most informative visit I have been involved in.
One star One star One star One star One star	27/03/2024	Very professional!
One star One star One star One star One star	27/03/2024	Highly professional interaction with the doctor.
One star One star One star One star One star	23/03/2024	Love the Doctor's kindness and compassion
One star One star One star One star One star	21/03/2024	Good
One star One star One star One star One star	21/03/2024	Dr Hoffmiester is great, has a great plan and explains it thoroughly
One star One star One star One star One star	21/03/2024	Dr Hoffmeister and Winship saved my life! They are God's hands on earth!
One star One star One star One star One star	16/03/2024	Your facility comes highly recommended and your employees never disappoint.
One star One star One star One star One star	13/03/2024	All good.
One star One star One star One star One star	13/03/2024	I have already told everyone what a good experience I had at this hospital
One star One star One star One star One star	27/02/2024	Good experience
One star One star One star One star One star	23/02/2024	Dr. Hofmeister is the greatest doctor in the whole world!!!
One star One star One star One star One star	22/02/2024	ALL GOOD
One star One star One star One star One star	16/02/2024	Dr Hofmeister was very kind he explained so well he listened and took so much time with me as a new patient and with my care team that was with me.
One star One star One star One star One star	15/02/2024	Dr Hofmeister has always shown concern about my condition and has been very helpful with coming up with different solutions..
One star One star One star One star One star	14/02/2024	Could not have been better.
One star One star One star One star One star	13/02/2024	Good experien
One star One star One star One star One star	08/02/2024	I am happy I entrusted Emory Healthcare and Dr Hofmeister with my care.
One star One star One star One star One star	07/02/2024	Totally happy with my experience.
One star One star One star One star One star	30/01/2024	I am very pleased that Dr. Craig Hofmeister is my myeloma specialist.
One star One star One star One star One star	30/01/2024	I have a high level of confidence in Rr Hoftmeister.. I will continue to seek treatment with Emory as long as I know they base their staff selection on merit, qualifications and achievement
One star One star One star One star One star	16/01/2024	Dr. Hofmeister reviewed current test results and progress. He offered flexibility to treatment to Increase QOL
One star One star One star One star One star	11/01/2024	Dr Hofmeister is smart & his health plan worked!
One star One star One star One star One star	06/01/2024	Everything about the experience was perfect
One star One star One star One star One star	04/01/2024	I would highly recommend Dr Hofmeister!!!!
One star One star One star One star One star	14/12/2023	He was very forthcoming about my care and what he was going to do and the event that something else come up and I appreciated it.
One star One star One star One star One star	10/12/2023	The dr is the best
One star One star One star One star One star	09/11/2023	The best!
One star One star One star One star One star	08/11/2023	Dr. Hofmeister was wonderful with spending the time with us needed to explain my diagnosis and any available treatment options.
One star One star One star One star One star	08/11/2023	Dr Hofmeister was very informative. I left feeling lvery comfortable with what he said. He's so smart and communicates in a way you can understand. Thanks to Dr Hofmeister!
One star One star One star One star One star	03/11/2023	Dr. Hofmeister has one of THE BEST bedside manners around. He makes you feel like he truly cares. He is able to be straightforward with truth, while at the same time empathizing with his patients and displaying the utmost kindness and consideration. He is the main reason I am still with Emory Winship. Should he ever leave, I will more than likely follow him.
One star One star One star One star One half star	30/10/2023	Good overall experience
One star One star One star One star One star	27/10/2023	Dr. Hofmeister is the ideal
One star One star One star One star One star	24/10/2023	Dr. Hofmeister is one of the most pleasant and understanding physicians I have ever dealt with.
One star One star One star One star One star	20/10/2023	Dr. Hofmeister explained all topics and answers to my questions thoroughly. He wrote out the main points of our conversation and handed me a printed copy as I was leaving. Much appreciated!
One star One star One star One star One star	18/10/2023	Provide excellent service. Explain all questions asked in detail
One star One star One star One star One star	18/10/2023	I received excellent care, feedback and a plan for further care. I was confident in the diagnosis.
One star One star One star One star One star	23/09/2023	Dr Hofmeister did a good job.
One star One star One star One star One half star	21/09/2023	Good
One star One star One star One star One star	14/09/2023	Meeting with Dr. Hofmeister's are alway thorough and productive. He is always on-time, prepared, and to the point, and takes time to address every question and concern.
One star One star One star One star Empty star	14/09/2023	I love Dr Hofmeister. Great bedside manners.
One star One star One star One star One star	06/09/2023	I like him he seems to be a great doctor and knows his job !
One star One star One star One star One star	31/08/2023	Good
One star One star One star One star One star	30/08/2023	Wish he could be my doctor through the entire process
One star One star One star One star One star	26/08/2023	Dr Hofmeister has been outstanding. He quickly put me at ease, is able to communicate at the right level for me and painted a clear picture of my status and care plan. Hers the best.
One star One star One star One star One star	19/08/2023	Great
One star One star One star One star One star	14/08/2023	Very informative
One star One star One star One star One star	05/08/2023	He's incredibly pleasant & informative!
One star One star One star One star Empty star	27/07/2023	I really like Dr. Hofmeister.
One star One star One star One star One star	20/07/2023	Doctor Hofmeister is a great doctor and I'm thankful for all his help.
One star One star One star One star One star	12/07/2023	Dr Hofmeister was excellent. I appreciate his direct, candid approach. He answered all my questions and even allowed me to push back on a couple of his responses, without becoming threatened - even welcomed this - in order for me to understand further or seek clarification. I am a person who likes to understand how, why, when, etc and he met and even exceeded my expectations
One star One star One star One star One star	12/07/2023	Couldn't be improved on!
One star One star One star One star One star	28/06/2023	Dr. Hofmeister is very caring and detailed in explaining the care needed and required, I trust his recommendations and at all times he is very professional in his delivery. Dr. Hofmeister is very good at clarifying and explaining diagnoses and prognoses that can be understood.
One star One star One star One star One star	23/06/2023	Dr.Holfmeister is the bomb!! I could not imagine getting better care than he gives me!!!
One star One star One star One star One star	14/06/2023	He explain everything to me very clearly
One star One star One star One star One star	08/06/2023	They answered all of my questions.
One star One star One star One star One star	30/05/2023	Dr Hofmeister is very thorough and genuine!
One star One star One star One star One star	26/05/2023	Excellent experience, goals acheived
One star One star One star One star One star	25/05/2023	I really appreciate being Dr. Hofmeister's patient for the last many years. He's a top notch doctor and is also funny at the same time. It really puts me at ease and to know that I trust his recommendations for treatments. Emory is fortunate to have him there.
One star One star One star One star One star	23/05/2023	Excellent
One star One star One star One star One star	23/05/2023	"Craig" was very detailed in explaining the disease process and treatment process
One star One star One star One star One star	20/05/2023	Dr Craig Hofmeister is wonderful! So kind and caring! Very concerned about his patients!
One star One star One star One star One star	20/05/2023	Excellent and kind Doctor. Would refer definitely
One star One star One star One star One star	19/05/2023	Excellent video conference
One star One star One star One star One star	11/05/2023	Excellent, caring, concerned doctor. He lets me know he really cares about me!
One star One star One star One star One star	06/05/2023	Dr Holfmeister is Fantastic as a human being and a very caring and knowledgeable Dr. Emory is Blessed to have him on Staff
One star One star One star One star One star	05/05/2023	Dr. Hoffmeister is outstanding.
One star One star One star One star One star	12/04/2023	He answered all my concerns and gave me head's up on my treatment plan. The good news as well as the bad.
One star One star One star One star One star	30/03/2023	Dr. Hofmeister is incredibly thorough and patient. He spent so much time with me making sure all my questions were answered.. I would be very comfortable with him being my Doctor.
One star One star One star One star One star	21/03/2023	4th opinion. Very impressive.
One star One star One star One star One star	18/03/2023	All were kind and informative
One star One star One star One star One star	16/03/2023	Dr. Hofmeister was in room real quick and no waiting!
One star One star One star One star One star	14/03/2023	Excellent
One star One star One star One star One star	09/03/2023	Dr HOFMEISTER is terrific
One star One star One star One star One star	08/03/2023	Dr.Craig is just super wonderful in my book. No body can out doctor him!!!
One star One star One star One star One star	14/02/2023	Easy to talk with listen and make clear recommendations
One star One star One star One star Empty star	02/02/2023	Very good experience with Dr. & Staff.
One star One star One star One star One star	27/01/2023	Dr. Hofmeister was great. He was very thorough and answered all our questions. Very professional and understanding.
One star One star One star One star One star	27/01/2023	I highly recommend Emory to all I have contact with
One star One star One star One star One star	08/12/2022	Highly recommend this Doctor.
One star One star One star One star One star	08/12/2022	We LOVE Dr Hofmeister. He has always been straightforward in our conversations with him.
One star One star One star One star One star	05/11/2022	Good
One star One star One star One star One star	01/11/2022	The team was excellent!!
One star One star One star One star One star	25/08/2022	Very competent and caring doctor
One star One star One star One star One star	23/08/2022	I learn so much from dr Hofmeister every time I speak with him
One star One star One star One star One star	11/08/2022	Absolutely great at all levels.
One star One star One star One star One star	14/07/2022	Treatment options given to read and make decisions on next visit.
One star One star One star One star One star	22/06/2022	I want to see the doctor and not the nurse practitioner as I only go once a year now.